<unk>  (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing<unk>  (Zyprexa), an atypical antipsychotic, and<unk>  (Prozac), a selective serotonin reuptake inhibitor (SSRI).<unk>  is primarily used to treat the depressive episodes of bipolar I disorder as well as treatment-resistant depression.
Olanzapine/fluoxetine
Aripiprazole/sertraline
Naltrexone/bupropion
Amitriptyline/chlordiazepoxide
Brief psychotherapy
Serdexmethylphenidate/dexmethylphenidate
Aripiprazole lauroxil
Insight-oriented psychotherapy